Literature DB >> 7795111

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

M R Joesoef1, G P Schmid.   

Abstract

We reviewed data on the treatment of bacterial vaginosis published from 1989 through 1992 (articles published after the 1989 publication of the Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines). This review suggests that oral metronidazole (500 mg twice daily for 7 days) is the preferred treatment for bacterial vaginosis. Other effective (but alternative) treatment regimens include single-dose metronidazole (2 g orally), 2% clindamycin vaginal cream (once daily for 7 days), 0.75% metronidazole vaginal gel (twice daily for 5 days), and oral clindamycin (300 mg twice daily for 7 days). Data do not support the practice of routine treatment of male sex partners of infected females. Treatment of bacterial vaginosis during pregnancy should focus on the elimination of symptoms; data on adverse pregnancy outcomes for women with bacterial vaginosis remain insufficient to recommend treatment of asymptomatic patients. Before performing surgical abortion, treatment of bacterial vaginosis (symptomatic or asymptomatic) should be considered to prevent pelvic inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795111     DOI: 10.1093/clinids/20.supplement_1.s72

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Infection and preterm delivery.

Authors:  P Brocklehurst
Journal:  BMJ       Date:  1999-02-27

2.  When to stop?

Authors:  Jon Eik Zwisler; John Larsen; Lars F Gram
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

3.  Should sexual partners of women with bacterial vaginosis receive treatment?

Authors:  J Potter
Journal:  Br J Gen Pract       Date:  1999-11       Impact factor: 5.386

Review 4.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 5.  Bacterial vaginosis-A brief synopsis of the literature.

Authors:  Makella S Coudray; Purnima Madhivanan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2019-12-24       Impact factor: 2.435

6.  Tinidazole in the treatment of bacterial vaginosis.

Authors:  Nicola R Armstrong; Janet D Wilson
Journal:  Int J Womens Health       Date:  2010-08-09

7.  Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.

Authors:  Lindsay Armstrong-Buisseret; Clare Brittain; Miruna David; Gillian Dean; Frances Griffiths; Trish Hepburn; Louise Jackson; Joe Kai; Alan Montgomery; Tracy Roberts; Sukhwinder Thandi; Jonathan D C Ross
Journal:  Trials       Date:  2019-11-27       Impact factor: 2.279

Review 8.  Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.

Authors:  Geisla Mary Silva Soares; Luciene Cristina Figueiredo; Marcelo Faveri; Sheila Cavalca Cortelli; Poliana Mendes Duarte; Magda Feres
Journal:  J Appl Oral Sci       Date:  2012 May-Jun       Impact factor: 2.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.